Literature DB >> 5480861

Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration.

T W Smith, E Haber.   

Abstract

A radioimmunoassay for serum digoxin concentration has been used to study the interrelationships of circulating levels of the drug and various factors in the clinical setting in 48 hospitalized patients with cardiac rhythm disturbances due to digoxin intoxication. 131 patients on maintenance doses of digoxin without toxicity and 48 patients with equivocal evidence of digoxin excess were also studied and compared with the toxic group. Patients with cardiac rhythm disturbances due to digoxin intoxication tended to be older and to have diminished renal function compared with the nontoxic group; body weight, serum potassium concentration, underlying cardiac rhythm, and nature of cardiac disease were not significantly different for the groups as a whole. Despite comparable mean daily digoxin dosages, digoxin intoxicated patients had a mean serum digoxin concentration of 3.7 +/-1.0 (SD) ng/ml, while nontoxic patients had a mean level of 1.4 +/-0.7 ng/ml (P < 0.001), 90% of patients without evidence of toxicity had serum digoxin concentrations of 2.0 ng/ml or less, while 87% of the toxic group had levels above 2.0; the range of overlap between the two groups extended from 1.6 to 3.0 ng/ml. Patients with atrioventricular block as their principal toxic manifestation had a significantly lower mean serum digoxin concentration than those in whom ectopic impulse formation was the chief rhythm disturbance. Patients with equivocal evidence of digoxin excess had received comparable daily maintenance doses of digoxin but had a mean serum concentration of 1.9 +/-0.8 ng/ml, intermediate between those of the nontoxic (P < 0.005) and toxic (P < 0.001) groups. Renal function as judged by mean blood urea nitrogen concentration was also intermediate. The data indicate that knowledge of the serum digoxin concentration, weighed in the clinical context, is useful in the management of patients receiving this drug.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5480861      PMCID: PMC322739          DOI: 10.1172/JCI106457

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

Review 2.  The clinical pharmacology of digitalis glycosides: a review.

Authors:  J E Doherty
Journal:  Am J Med Sci       Date:  1968-06       Impact factor: 2.378

3.  Alteration of the body distribution of tritiated digoxin by acute hyperkalemia in the dog.

Authors:  F I Marcus; G G Kapadia; C Goldsmith
Journal:  J Pharmacol Exp Ther       Date:  1969-01       Impact factor: 4.030

4.  An improved method for measuring plasma and tissue concentrations of digitalis glycosides.

Authors:  J M Lowenstein; E M Corrill
Journal:  J Lab Clin Med       Date:  1966-06

5.  Digitalis-induced arrhythmias and their management.

Authors:  G V Irons; E S Orgain
Journal:  Prog Cardiovasc Dis       Date:  1966-05       Impact factor: 8.194

6.  Tissue concentration and turnover of tritiated digoxin in dogs.

Authors:  J E Doherty; W H Perkins
Journal:  Am J Cardiol       Date:  1966-01       Impact factor: 2.778

7.  The distribution and concentration of tritiated digoxin in human tissues.

Authors:  J E Doherty; W H Perkins; W J Flanigan
Journal:  Ann Intern Med       Date:  1967-01       Impact factor: 25.391

8.  Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.

Authors:  J E Doherty; W H Perkins
Journal:  Ann Intern Med       Date:  1966-03       Impact factor: 25.391

9.  Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.

Authors:  D G Grahame-Smith
Journal:  Br Med J       Date:  1969-02-01

10.  The measurement of digitoxin in human serum by radioimmunoassay.

Authors:  G C Oliver; B M Parker; D L Brasfield; C W Parker
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  55 in total

1.  Editorial: Problems with digoxin.

Authors: 
Journal:  Br Med J       Date:  1975-01-11

2.  Postmortem assay of digoxin by radioimmunoassay.

Authors:  D W Holt; J G Benstead
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

Review 3.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  ABC of monitoring drug therapy. Digoxin.

Authors:  J K Aronson; M Hardman
Journal:  BMJ       Date:  1992-11-07

5.  THE MEASUREMENT OF CARDIAC GLYCOSIDE CONCENTRATIONS.

Authors:  Linda Monroe; John A. Burdine
Journal:  Cardiovasc Dis       Date:  1974

Review 6.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

7.  Radioimmunoassay of serum digoxin in relation to digoxin intoxication.

Authors:  R B Singh; A N Rai; D P Dube; D K Srivastav; P N Somani; B C Katiyar
Journal:  Br Heart J       Date:  1975-06

8.  Suspected adverse drug reactions in elderly patients reported to the Committee on Safety of Medicines.

Authors:  C M Castleden; H Pickles
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

9.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors:  S M Dobbs; W I Kenyon; R J Dobbs
Journal:  Br Med J       Date:  1977-03-19

10.  Differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis.

Authors:  J C Somberg; W H Barry; T W Smith
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.